Literature DB >> 2825964

N-myc amplification in Wilms' tumor.

M D Norris, M J Brian, M R Vowels, B W Stewart.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 2825964     DOI： 10.1016/0165-4608(88)90112-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


× No keyword cloud information.
  5 in total

1.  Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Authors:  Richard D Williams; Reem Al-Saadi; Tasnim Chagtai; Sergey Popov; Boo Messahel; Neil Sebire; Manfred Gessler; Jenny Wegert; Norbert Graf; Ivo Leuschner; Mike Hubank; Chris Jones; Gordan Vujanic; Kathy Pritchard-Jones
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

2.  N-myc oncogene amplification in paediatric tumours.

Authors:  S McQuaid; A O'Meara
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

Review 3.  The yin and yang of kidney development and Wilms' tumors.

Authors:  Peter Hohenstein; Kathy Pritchard-Jones; Jocelyn Charlton
Journal:  Genes Dev       Date:  2015-03-01       Impact factor: 11.361

4.  Multiple mechanisms of MYCN dysregulation in Wilms tumour.

Authors:  Richard D Williams; Tasnim Chagtai; Marisa Alcaide-German; John Apps; Jenny Wegert; Sergey Popov; Gordan Vujanic; Harm van Tinteren; Marry M van den Heuvel-Eibrink; Marcel Kool; Jan de Kraker; David Gisselsson; Norbert Graf; Manfred Gessler; Kathy Pritchard-Jones
Journal:  Oncotarget       Date:  2015-03-30

Review 5.  Biological Drivers of Wilms Tumor Prognosis and Treatment.

Authors:  Hannah M Phelps; Saara Kaviany; Scott C Borinstein; Harold N Lovvorn
Journal:  Children (Basel)       Date:  2018-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.